JCI

Johnson Controls International Sees 7% Sales Growth in Q4

Johnson Controls International PLC has reported its fiscal fourth quarter and full-year 2024 results, showing a positive trend in sales and earnings. In the fourth quarter, the company saw a 7% increase in sales to $7.4 billion, with organic sales also rising by 10%. Full-year sales increased by 2% to $27.4 billion, and organic sales grew by 4%.

The GAAP earnings per share (EPS) for the fourth quarter were $0.95, while the adjusted EPS stood at $1.28. For the full year, GAAP EPS was $2.52, and adjusted EPS was $3.71.

The company's backlog for building solutions increased by 7% organically year-over-year, reaching $13.1 billion. Notably, orders in the fourth quarter increased by 8% organically year-over-year.

In terms of segment results, the Building Solutions North America segment reported a 16% increase in sales to $3.2 billion, with organic sales also rising by 16%. The Building Solutions EMEA/LA segment saw a 7% increase in sales to $1.1 billion, with organic sales growing by 10%. Sales for the Building Solutions Asia Pacific segment declined by 5% to $664 million, with organic sales also dropping by 5%. The Global Products segment reported flat sales at $2.4 billion, but organic sales grew by 8%.

The company's corporate expenses increased by 126%, reaching $158 million in the fourth quarter. Johnson Controls also reported total cash provided by operating activities of $1,526 million, with free cash flow at $1,318 million and adjusted free cash flow at $1,087 million. The company paid dividends of $247 million and repurchased 5.4 million shares of common stock for approximately $370 million.

Looking ahead, Johnson Controls provided guidance, including a multi-year restructuring plan that is expected to result in approximately $500 million in annual cost savings following an investment of around $400 million over the next three years.

Following these announcements, the company's shares moved 6.1%, and are now trading at a price of $79.42. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS